Cutting edge: the prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients J Andersson, A Boasso, J Nilsson, R Zhang, NJ Shire, S Lindback, ... The Journal of Immunology 174 (6), 3143-3147, 2005 | 453 | 2005 |
HIV-1–driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS J Nilsson, A Boasso, PA Velilla, R Zhang, M Vaccari, G Franchini, ... Blood 108 (12), 3808-3817, 2006 | 435 | 2006 |
HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells A Boasso, JP Herbeuval, AW Hardy, SA Anderson, MJ Dolan, D Fuchs, ... Blood 109 (8), 3351-3359, 2007 | 382 | 2007 |
CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon–dependent, TRAIL/DR5-mediated apoptosis JP Herbeuval, JC Grivel, A Boasso, AW Hardy, C Chougnet, MJ Dolan, ... Blood 106 (10), 3524-3531, 2005 | 282 | 2005 |
Chronic innate immune activation as a cause of HIV-1 immunopathogenesis A Boasso, GM Shearer Clinical immunology 126 (3), 235-242, 2008 | 276 | 2008 |
B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression D Trabattoni, M Saresella, M Biasin, A Boasso, L Piacentini, P Ferrante, ... Blood, The Journal of the American Society of Hematology 101 (7), 2514-2520, 2003 | 238 | 2003 |
Regulation of indoleamine 2, 3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells A Boasso, JP Herbeuval, AW Hardy, C Winkler, GM Shearer Blood 105 (4), 1574-1581, 2005 | 230 | 2005 |
Differential expression of IFN-α and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients JP Herbeuval, J Nilsson, A Boasso, AW Hardy, MJ Kruhlak, SA Anderson, ... Proceedings of the National Academy of Sciences 103 (18), 7000-7005, 2006 | 220 | 2006 |
Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells JP Herbeuval, AW Hardy, A Boasso, SA Anderson, MJ Dolan, M Dy, ... Proceedings of the National Academy of Sciences 102 (39), 13974-13979, 2005 | 209 | 2005 |
TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1–infected patients and its in vitro production by antigen-presenting cells JP Herbeuval, A Boasso, JC Grivel, AW Hardy, SA Anderson, MJ Dolan, ... Blood 105 (6), 2458-2464, 2005 | 204 | 2005 |
CTLA-4 blockade decreases TGF-β, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques A Hryniewicz, A Boasso, Y Edghill-Smith, M Vaccari, D Fuchs, D Venzon, ... Blood 108 (12), 3834-3842, 2006 | 199 | 2006 |
Neuroinflammation in treated HIV-positive individuals: a TSPO PET study JH Vera, Q Guo, JH Cole, A Boasso, L Greathead, P Kelleher, EA Rabiner, ... Neurology 86 (15), 1425-1432, 2016 | 165 | 2016 |
HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation A Boasso, AW Hardy, SA Anderson, MJ Dolan, GM Shearer PloS one 3 (8), e2961, 2008 | 154 | 2008 |
Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection V Cecchinato, E Tryniszewska, ZM Ma, M Vaccari, A Boasso, WP Tsai, ... The Journal of Immunology 180 (8), 5439-5447, 2008 | 148 | 2008 |
Regulatory T-cell markers, indoleamine 2, 3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection A Boasso, M Vaccari, A Hryniewicz, D Fuchs, J Nacsa, V Cecchinato, ... Journal of virology 81 (21), 11593-11603, 2007 | 125 | 2007 |
Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it? A Boasso, GM Shearer, C Chougnet Journal of internal medicine 265 (1), 78-96, 2009 | 118 | 2009 |
PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes A Boasso, AW Hardy, AL Landay, JL Martinson, SA Anderson, MJ Dolan, ... Clinical immunology 129 (1), 132-144, 2008 | 87 | 2008 |
How does indoleamine 2, 3-dioxygenase contribute to HIV-mediated immune dysregulation A Boasso, GM Shearer Current drug metabolism 8 (3), 217-223, 2007 | 87 | 2007 |
Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques A Boasso, M Vaccari, D Fuchs, AW Hardy, WP Tsai, E Tryniszewska, ... The Journal of Immunology 182 (7), 4313-4320, 2009 | 85 | 2009 |
Changes in T cell and dendritic cell phenotype from mid to late pregnancy are indicative of a shift from immune tolerance to immune activation NM Shah, AA Herasimtschuk, A Boasso, A Benlahrech, D Fuchs, N Imami, ... Frontiers in immunology 8, 295483, 2017 | 76 | 2017 |